ASPE insider filings
Aspen Neuroscience, Inc. — 21 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-09. Screen ASPE transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 21 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings by 16 insiders — 4,533,333 shares, $67,999,995 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: purchase of 1,200,000 shares @ $15.00 ($18,000,000) by ARCH Venture Fund X, L.P., filed 2026-11-02.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
+5 more insiders in the window, not shown — every filing appears in the table below.
Recent insider filings — Aspen Neuroscience, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-09 | 4 | Hasnain Faheem — Executive Chair, Director | Grant/award (A): 321,672 @ $0 | EDGAR |
| 2026-11-04 | 4 | Thompson Peter A. — Director, 10% owner | Conversion (C): 196,541 · Conversion (C): 642,745 · Conversion (C): 616,984 · Conversion (C): 625,743 · Conversion (C): 507,119 · Purchase (P): 1,000,000 @ $15 · +5 more | EDGAR |
| 2026-11-04 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner | Conversion (C): 196,541 · Conversion (C): 642,745 · Conversion (C): 616,984 · Conversion (C): 625,743 · Conversion (C): 507,119 · Purchase (P): 1,000,000 @ $15 · +5 more | EDGAR |
| 2026-11-02 | 4 | ARCH Venture Fund X, L.P. — 10% owner ARCH Venture Fund X Overage, L.P. — 10% owner ARCH Venture Partners X, L.P. — 10% owner ARCH Venture Partners X Overage, L.P. — 10% owner ARCH Venture Partners X, LLC — 10% owner CRANDELL KEITH — 10% owner Burow Kristina — 10% owner GILLIS STEVEN — 10% owner NELSEN ROBERT — 10% owner | Purchase (P): 66,666 @ $15 · Conversion (C): 187,182 · Conversion (C): 298,258 · Conversion (C): 286,304 · Conversion (C): 295,490 · Conversion (C): 259,948 · +15 more | EDGAR |
| 2026-11-02 | 4 | ARCH Venture Partners XIV, L.P. — 10% owner ARCH Venture Partners XIV, LLC — 10% owner ARCH Venture Fund XIV, L.P. — 10% owner BERNS PAUL L — 10% owner | Purchase (P): 1,200,000 @ $15 | EDGAR |
| 2026-11-02 | 4 | Spaventa Andrew — Director | Conversion (C): 70,194 · Conversion (C): 180,221 · Conversion (C): 70,194 (derivative) · Conversion (C): 180,221 (derivative) | EDGAR |
| 2026-11-02 | 4 | Hasnain Faheem — Executive Chair, Director | Conversion (C): 14,913 · Conversion (C): 14,316 · Conversion (C): 7,120 · Conversion (C): 14,913 (derivative) · Conversion (C): 14,316 (derivative) · Conversion (C): 7,120 (derivative) | EDGAR |
| 2026-10-29 | 3 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VII LLC — Director, 10% owner | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Boerneke Jeffrey Lee — General Counsel and Secretary | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Spaventa Andrew — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Hasnain Faheem — Executive Chair, Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Daniel Thomas O — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | ARCH Venture Fund X, L.P. — 10% owner ARCH Venture Fund X Overage, L.P. — 10% owner ARCH Venture Partners X, L.P. — 10% owner ARCH Venture Partners X Overage, L.P. — 10% owner ARCH Venture Partners X, LLC — 10% owner CRANDELL KEITH — 10% owner Burow Kristina — 10% owner GILLIS STEVEN — 10% owner NELSEN ROBERT — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Thompson Peter A. — Director, 10% owner | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | McDevitt Damien — See Remarks, Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Fisher Douglas Carl — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Peterson Caryn — Director | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Meeter Dalen — Chief Financial Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Johnson-Pratt Lisa — Chief Commercial Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Raineri Kim — Chief Technology Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-29 | 3 | Perettie Cynthia Dorothy — Director | Holdings only — no transactions reported | EDGAR |
Recent 8-K events — Aspen Neuroscience, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-02 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Aspen Neuroscience, Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-299393 (S-1) — latest: Final prospectus (424B4), filed 2026-10-30
GET https://api.filingpulse.io/v1/insider-trades?ticker=ASPE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs